Transparency-related provisions in the summary of the chairman's mark that Sen. Max Baucus and the Senate Finance Committee released last week: Lots of new disclosure requirements for physicians who refer patients to hospitals in which they or their family members have a financial interest, for nursing homes, for hospitals, for medical device manufacturers, suppliers, and pharmaceutical companies. Little oversight of government (there's a few requirements for new entities created by the bill to act in a transparent manner). Still, what's more interesting is what's not transparent -- updates on that coming later. Here's the descriptions of ...